Detalles de la búsqueda
1.
A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients' and physicians' preferences and adherence.
Scand J Gastroenterol
; 57(3): 274-281, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779308
2.
Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on biologics.
Scand J Gastroenterol
; 57(9): 1051-1057, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35412932
3.
Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort study.
Scand J Gastroenterol
; 50(8): 1018-24, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25861832
4.
Exploring disease-related and treatment-related issues and concerns experienced by adults with spondyloarthritis, inflammatory bowel disease and psoriasis to identify unmet needs: a qualitative clinical concept mapping study.
BMJ Open
; 13(12): e071586, 2023 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38081674
5.
Identifying and understanding disease burden in patients with inflammatory bowel disease.
BMJ Open Gastroenterol
; 9(1)2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36302557
6.
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease.
NEJM Evid
; 1(8): EVIDoa2200061, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319804
7.
Biodegradable stents for the treatment of bowel strictures in Crohn's disease: technical results and challenges.
Endosc Int Open
; 4(3): E296-300, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27004247
8.
[Prevention of infections in patients with inflammatory bowel disease during TNF inhibitor treatment].
Ugeskr Laeger
; 176(48)2014 Nov 24.
Artículo
en Da
| MEDLINE | ID: mdl-25430572
Resultados
1 -
8
de 8
1
Próxima >
>>